#Humans

  1. Loneliness and Social Isolation in Older Adults
  2. Interpersonal sensitivity and response to selective serotonin reuptake inhibitors in patients with acute major depressive disorder
  3. Body grammar and its meanings: an ethnography of the clinical context on language, and motor aphasia in a hospital in Mexico City
  4. Internet psychotherapeutic interventions for anxiety disorders—A critical evaluation
  5. Revisiting the Role of Augmentative and Alternative Communication in Aphasia Rehabilitation
  6. Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: A mega-analysis of citalopram and paroxetine in adult depression
  7. Cross-sectional networks of depressive symptoms before and after antidepressant medication treatment
  8. "Pain Is What the Patient Says It Is": Nurse-Patient Communication, Information Seeking, and Pain Management
  9. "Pain Is What the Patient Says It Is": Nurse-Patient Communication, Information Seeking, and Pain Management
  10. Reliability of the Danish Abbey Pain Scale in severely demented and non-communicative older patients
  11. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations
  12. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
  13. Evidence-based somatic treatment of depression in adults
  14. Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: Escitalopram vs paroxetine
  15. Helping novice nurses make effective clinical decisions: the situated clinical decision-making framework
  16. Selective serotonin reuptake inhibitors for unipolar depression: A systematic review of classic long-term randomized controlled trials
  17. How often do SSRIs and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is low
  18. Publication bias in systematic reviews
  19. Spirituality and the care of patients at the end-of-life: An essential component of care
  20. Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action
  21. Escitalopram maintenance treatment for prevention of recurrent depression: A randomized, placebo-controlled trial
  22. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: A meta-analysis
  23. Two items on the Hamilton Depression rating scale are effective predictors of remission: Comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine
  24. Fixed-dose trial of the single isomer SSRI Escitalopram in depressed outpatients
  25. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo
  26. Efficacy of SSRIs and newer antidepressants in severe depression: Comparison with TCAs
  27. The treatment of severe depression: Is there an efficacy gap between SSRI and TCA antidepressant generations?
  28. Placebo-controlled efficacy of antidepressants in continuation treatment